Drugs / citric acid
citric acid
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | IRRIGATING SOLUTION G IN PLASTIC CONTAINER | — | 1982-06-22 | fda.gov ↗ |
Trials 13 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT07700277 | Aug 2026 → Aug 2027 expected | intestinal disorder | Ottawa Hospital Research Institute | Not yet recruiting | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT01421160 | Jul 2011 → Mar 2012 | arthritic joint disease | Texas Tech University Health Sciences Center, El Paso | Withdrawn | No outcome recorded |
| Phase 2/33 trials | ||||||
| Phase 2/3 | NCT05918029 | Aug 2024 → Aug 2026 overdue | bone resorption disease, chronic kidney disease | Albert Einstein College of Medicine | Recruiting | No outcome recorded |
| Phase 2/3 | NCT04842331 | Sep 2021 → Jan 2022 | COVID-19, viral respiratory tract infection | Thirty Respiratory Limited | Withdrawn | No outcome recorded |
| Phase 2/3 | NCT01012349 | Feb → May 2011 | — | Azidus Brasil | Unknown | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT04386070 | May 2022 → Dec 2026 | COVID-19, severe acute respiratory syndrome | University of Birmingham | Suspended | No outcome recorded |
| Phase 3 | NCT01984008 | Oct 2013 → Mar 2014 | — | Universal Integrated Corp. | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT04161599 | Mar 2022 → Jun 2024 | — | Hospital Universitari Vall d'Hebron Research Institute | Unknown | No outcome recorded |
| Phase 4 | NCT01481714 | Nov 2011 → Mar 2012 | — | Infante, Javier Molina, M.D. | Unknown | No outcome recorded |
| Phase not applicable4 trials | ||||||
| — | NCT07708792 | Aug → Oct 2026 expected | gingival disorder | Dijlah University | Not yet recruiting | No outcome recorded |
| — | NCT06042738 | Mar → Nov 2021 | male infertility | Ondokuz Mayıs University | Completed | No outcome recorded |
| — | NCT04033250 | Sep 2019 → Sep 2020 | — | Rambam Health Care Campus | Unknown | No outcome recorded |
| — | NCT02359942 | Mar 2015 → Dec 2018 | Helicobacter pylori infectious disease | Seoul National University Bundang Hospital | Completed | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT02015260 Comparator | Sep 2001 → May 2003 | anogenital human papillomavirus infection | University of Aberdeen | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT03769402 Comparator | Jan 2016 → May 2018 | periodontal disorder | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT00586131 Comparator | Sep 2003 → Apr 2008 | end stage renal failure | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 16 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | citric acid | “food supplement containing 2000 mg L-carnitine, 2000 mg fructose, 932 mg acetyl L-carnitine, 225 mg vitamin C, 115 mg citric acid, 50 mg coenzyme Q10, 14 mg zinc, 115 µg...” NCT06042738 ↗14“RESP301 is a formulation consisting of three agents already used in clinical practice: mannitol, sodium nitrite and citric acid.” NCT04386070 ↗ “RESP301 is a formulation consisting of 3 agents currently used in clinical practice: mannitol, sodium nitrite and citric acid.” NCT04842331 ↗ “A) 3% sodium nitrite + 4.5% citric acid creams twice daily” NCT02015260 ↗ |
| Known as | anhydrous citric acid | “Drug: Sodium picosulfate, light magnesium oxide, anhydrous citric acid 10 mg/3.5 g/10.97 g Oral” NCT04161599 ↗ |
| Known as | sodium citrate/citric acid | “Arterial pH was varied by changing the daily doses of sodium citrate/citric acid and ammonium chloride.” PMID 19846545 ↗ Oct 2009 |
| Route | Oral | “association Geolab consisting of acetylsalicylic acid, sodium bicarbonate and anhydrous citric acid - oral powder” NCT01012349 ↗ |